ABOUT SOUTH ASIA BIOBANK
South Asia Biobank is a longitudinal population study of ~200,000 participants which has been designed to understand and help prevent the high risk of cardiovascular disease, diabetes, and other common and critical illnesses among people of South Asian origin.
We will recruit ~100,000 South Asians in the UK (as part of the LOLIPOP 100K Study), and a further ~100,000 people in South Asia (as part of our NIHR Global Health Research Unit). We will collect detailed health and lifestyle data, and blood samples using standardised methodology, in all participants. With their permission, we will follow-up participants for health outcomes over the next 30 years or more to help understand, prevent, and treat the causes of major critical illnesses in South Asians. In doing this, we aim to improve the health and well-being of South Asians world-wide, who comprise ¼ of the world’s population.
WHY SHOULD I PARTICIPATE?
This study is designed to understand why South Asians are at high risk of heart disease, diabetes, and other critical illnesses. Your participation in the study will transform research today and benefit tomorrow’s health among millions of South Asians worldwide.
WHY IS THIS STUDY BEING CARRIED OUT ?
Much progress in medical science has been made in the past five decades but this has not provided answers to why South Asians remain at such high risk of cardiovascular disease, diabetes, and other critical illnesses compared to other populations.
To date, most large-scale studies have largely recruited people of European ancestry. This lack of diversity in research hinders our understanding of reasons why populations such as South Asians are more susceptible to certain illnesses.
The absence of South Asians in research studies has added to unacceptable health disparities, and raises the question of whether new diagnostics, and treatments derived from research will benefit all populations equally.
South Asia Biobank is designed to bring together the largest world-wide resource of biological data in-order to address critical questions, such as why South Asians remain at X3 risk of diabetes and x 2 risk of cardiovascular disease and other critical illnesses. – we are establishing the South Asia Biobank to do just that.
South Asia Biobank will be a major world-wide resource for medical researchers for decades to come. The more information we can arm ourselves with about serious conditions like diabetes, the more chance we have of preventing disease, finding new treatments and even cures.
Your participation will transform research today and benefit tomorrow’s health among millions of South Asians worldwide
“We aim to recruit some 200,000 people aged 25-85 over the next three years to understand how genes, lifestyle and the environment interact and result in high rates of heart disease, diabetes, and other critical illnesses among South Asians.”
Professor Jaspal S Kooner, Director South Asia Biobank
Contact us for more info
If you are interested in joining the team, have any questions or would like to find out more about the South Asia Biobank please complete the form below and one of the team will be in touch.